deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT06635317

Efficacy of Aspirin in Preventing Venous Thromboembolism

Efficacy of Arpirin in Preventing Venous Thromboembolism in Total Knee and Hip Replacement

Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Conditions Total Hip Arthroplasty (THA) Total Joint Arthroplasty Venous Thromboembolism (VTE)
Interventions Aspirin enoxaparin
Updated 2 times since 2024 Last updated: Oct 8, 2024 Started: Apr 24, 2022 Primary completion: Oct 24, 2022 Completion: Feb 28, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Total Hip Arthroplasty (THA) and Total Joint Arthroplasty, this trial is completed. The trial is conducted by Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado and has accumulated 2 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Nov 2024 — Sep 2025 [monthly]

    Completed PHASE4

    First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Data source: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations